Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 2701–2750 of 34667
On April 18, 2025, the Board of Directors of MediXall Group, Inc. (the "Company") appointed the following as members of the Board of Directors: Susan Poniatowski, Garth Walker, Gene Shvedov.
On April 18, 2025, the Board of Directors of MediXall Group, Inc. (the "Company") appointed the following as members of the Board of Directors: Susan Poniatowski, Garth Walker, Gene Shvedov.
On April 18, 2025, the Board of Directors of MediXall Group, Inc. (the "Company") appointed the following as members of the Board of Directors: Susan Poniatowski, Garth Walker, Gene Shvedov.
In addition, on April 18, 2025, the Board of Directors accepted the resignations of Travis Jackson and John Marino
In addition, on April 18, 2025, the Board of Directors accepted the resignations of Travis Jackson and John Marino
the Board, upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Dr. Poma to serve as a Class I director of the Company, also effective April 22, 2025
On April 22, 2025, Jake Kurtis notified the Company of his immediate resignation as a director of the Company to pursue other interests.
On April 20, 2025, George Kelly Martin informed the Board of Directors (the “Board”) of TriSalus Life Sciences, Inc. (the “Company”) of his decision to resign from his position as a member of the Board, the Audit Committee of the Board and the Compensation Committee of the Board, effective immediately.
On April 22, 2025, the board of directors of the Company (the "Board") also elected Mr. Stepien to serve as a Class I director, effective May 1, 2025.
On April 17, 2025, SoundThinking, Inc. (the “Company”) announced that Burton Goldfield had been appointed to the Board of Directors (the “Board”) of the Company as a Class II director.
Election of New Director On April 16, 2025, the Board of Directors (the “Board”) of the Company elected Ms. Danielle Sheer to serve as a member of the Board, as a Class II director, and appointed her to serve on the Nomination and Governance Committee, both effective as of May 13, 2025.
Ms. Sheer initially will serve the remainder of the term of co-founder and long-term director Mr. Deepak Raghavan, who is retiring as of May 13, 2025.
On April 21, 2025, the Board of Directors (the “Board”) of Sight Sciences, Inc. (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee, appointed Gerhard F. Burbach to the Board.
Philip E. Norment was not nominated for re-election to the Board of Directors of Ryerson Holding Corporation (“Ryerson” or the “Company”), and effective as of April 17, 2025, he ceased to serve as a director of the Company.
Wei Hopeman has informed Booking Holdings Inc. (the "Company") that she has decided to retire from the Company's Board of Directors (the "Board"), effective at the Company's Annual Meeting in June 2025 (the "Annual Meeting"), and therefore is not standing for re-election at the Annual Meeting.
On April 16, 2025, the Board of Directors (“Board”) of Jabil Inc. (“Jabil”), increased the size of the Board from nine to ten directors and appointed Ms. Sujatha Chandrasekaran to the Board, effective immediately and continuing until the next annual meeting of stockholders or until her successor is duly elected and qualified.
On April 18, 2025, the board of directors (the “ Board ”) of Churchill Capital Corp IX (the “ Company ”) appointed Paul D. Lapping as a director and as a member of the audit committee and the compensation committee of the Board, effective as of April 18, 2025.
On April 16, 2025, Madan Menon resigned from the board of directors (the “ Board ”) of Zoomcar Holdings, Inc.
On April 17, 2025, Asako Aoyama, a member of the Board of Directors (the “Board”) of Aviat Networks, Inc. (“Aviat” or the “Company”) notified the Company that she would be resigning from the Board effective on April 22, 2025.
Subsequently on April 21, 2025, Mr. Batchelor resigned from the Board, effective immediately as of such date.
Diane Holder notified the Board of Directors (the “Board”) of Evolent Health, Inc. (the “Company”) that she will not stand for re-election to the Board at the Company’s annual meeting of stockholders scheduled to be held on June 5, 2025 (the “2025 Annual Meeting”).
FKP Advisors LLC board seat will be on a rotational basis with Larry Kloess III serving in the first year, followed by Jim Fitzgerald in the second year, and Ben Pope in the third year.
FKP Advisors LLC board seat will be on a rotational basis with Larry Kloess III serving in the first year, followed by Jim Fitzgerald in the second year, and Ben Pope in the third year.
FKP Advisors LLC board seat will be on a rotational basis with Larry Kloess III serving in the first year, followed by Jim Fitzgerald in the second year, and Ben Pope in the third year.
On April 10, 2025, the Board appointed Guoquan (Paul) Huang to serve on the board of directors, effective upon the closing of the Private Placement and the satisfactory completion of a background check, as a Class II director for a term expiring at the 2026 annual meeting of stockholders and until his successor is elected and qualified or until his earlier death, resignation or removal or as otherwise provided in the bylaws of the Company.
Mr. Shapiro will fulfill the remainder of his term as member of the Board of Directors and the effective date of his departure will be the Company’s Annual Meeting of Shareholders, June 10, 2025.
On April 17, 2025, the Board of Directors of PPG Industries, Inc. (the “Company”) elected Leon J. Topalian as a director of the Company, effective July 16, 2025.
Upon the consummation of the Merger, each of Albert DaCosta, Quentin Blackford, Dave Demski, Alf Grunwald, B. Kris Johnson, Stephen Oesterle, Megan Scanlon, Tom Schnettler and Krissy Wright ceased to be a member of the board of directors of the Company.
Upon the consummation of the Merger, each of Albert DaCosta, Quentin Blackford, Dave Demski, Alf Grunwald, B. Kris Johnson, Stephen Oesterle, Megan Scanlon, Tom Schnettler and Krissy Wright ceased to be a member of the board of directors of the Company.
Upon the consummation of the Merger, each of Albert DaCosta, Quentin Blackford, Dave Demski, Alf Grunwald, B. Kris Johnson, Stephen Oesterle, Megan Scanlon, Tom Schnettler and Krissy Wright ceased to be a member of the board of directors of the Company.
Upon the consummation of the Merger, each of Albert DaCosta, Quentin Blackford, Dave Demski, Alf Grunwald, B. Kris Johnson, Stephen Oesterle, Megan Scanlon, Tom Schnettler and Krissy Wright ceased to be a member of the board of directors of the Company.
Upon the consummation of the Merger, each of Albert DaCosta, Quentin Blackford, Dave Demski, Alf Grunwald, B. Kris Johnson, Stephen Oesterle, Megan Scanlon, Tom Schnettler and Krissy Wright ceased to be a member of the board of directors of the Company.
Upon the consummation of the Merger, each of Albert DaCosta, Quentin Blackford, Dave Demski, Alf Grunwald, B. Kris Johnson, Stephen Oesterle, Megan Scanlon, Tom Schnettler and Krissy Wright ceased to be a member of the board of directors of the Company.
Upon the consummation of the Merger, each of Albert DaCosta, Quentin Blackford, Dave Demski, Alf Grunwald, B. Kris Johnson, Stephen Oesterle, Megan Scanlon, Tom Schnettler and Krissy Wright ceased to be a member of the board of directors of the Company.
Upon the consummation of the Merger, each of Albert DaCosta, Quentin Blackford, Dave Demski, Alf Grunwald, B. Kris Johnson, Stephen Oesterle, Megan Scanlon, Tom Schnettler and Krissy Wright ceased to be a member of the board of directors of the Company.
Upon the consummation of the Merger, each of Albert DaCosta, Quentin Blackford, Dave Demski, Alf Grunwald, B. Kris Johnson, Stephen Oesterle, Megan Scanlon, Tom Schnettler and Krissy Wright ceased to be a member of the board of directors of the Company.
On April 16, 2025, Mr. Joseph Manko, Jr. notified the Board of Directors (the “Board”) of One Stop Systems, Inc. (the “Company”) of his resignation from the Board, effective immediately.
Effective April 16, 2025, Mr. Hicks no longer serves as a member of the Old Dominion Electric Cooperative board of directors.
On April 21, 2025, the Board of Directors (the “Board”) of P10, Inc. (the “Company”), based on the recommendation of the Nominating and Corporate Governance Committee, appointed Jennifer Glassman as a Class I director, with a term expiring at the Company’s 2025 annual meeting of stockholders, and Stephen Blewitt as a Class III director, with a term expiring at the Company’s 2027 annual meeting of stockholders, to fill the two current vacancies on the Board.
On April 21, 2025, the Board of Directors (the “Board”) of P10, Inc. (the “Company”), based on the recommendation of the Nominating and Corporate Governance Committee, appointed Jennifer Glassman as a Class I director, with a term expiring at the Company’s 2025 annual meeting of stockholders, and Stephen Blewitt as a Class III director, with a term expiring at the Company’s 2027 annual meeting of stockholders, to fill the two current vacancies on the Board.
On April 18, 2025, the Board of Directors (the “Board”) of Ramaco Resources, Inc. (the “Company”) approved the appointment of former US Senator Joseph Manchin III to serve as a member of the Board effective April 18, 2025, with a term expiring at the Company’s annual meeting of stockholders in 2025 or until his earlier death, resignation, disqualification, or removal.
William (Bill) Koeck, a current member of the Board of Directors (the “Board”) of Coronado Global Resources Inc. (the “Company”), notified the Board that he will not stand for reelection as a director upon expiration of his current term
On April 16, 2025, the board of directors (the “Board”) of New Jersey Resources Corporation ("NJR" or the "Company") increased the size of the Board from ten to eleven directors and unanimously elected William T. Yardley as a director, effective as of July 1, 2025.
provided the Board with notice of his intent not to stand for reelection to the Board at the 2025 Annual Meeting of Stockholders.
On April 17, 2025, the Board of Directors (the “Board”) of Apellis Pharmaceuticals, Inc. (the “Company”), upon recommendation from the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), elected Craig A. Wheeler to the Board as a Class III director to serve until the Annual Meeting of Stockholders to be held in 2026 or until his successor has been duly elected and qualified or until his earlier death, resignation or removal.
each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof
each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof
each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof
each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof
each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.